Euroscicon Ltd like to take this opportunity to welcome all of you to “11th Edition of International Conference on Proteomics” which is to be held during March 22-23, 2018 at London, UK. Through our theme “Exploring Novel Drug in the Field of Proteomics”, the conference will analyse the recent advancements and new modes that can be enforced to the research to take Proteomics, one step further.
Proteomics 2018 will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. The conference also includes essential topics on: Proteomics in Drug Discovery, Protein Expression and Analysis, Chromatin Proteomics, Protein Microarrays , The Cancer Proteome, Proteomics for Bioinformatics, Neuroproteomics, Proteomics and Cell Signalling, Metabolomics, Transcriptome Sequencing, Phylogenetic Analysis of Protein, Genomic, Proteomic and Metabolomic Data Integration Strategies and Molecular Docking and Structure-Based Drug Design Strategies.
Hence, we welcome you all to be a part of this event to contribute your novel research ideas.
The study of Proteomics is important as it represents the actual functional molecules in the cell. When mutations occurs in DNA, ultimately proteins are affected. . The major goal of proteomics study helps in understanding the function of proteins and their role by advance technology in order to find a novel drug. When pathogens infect, causing disease these proteins play a major role in signalling the presence & ridding us of these invaders. Almost in each and every process that occurs in our cells from the metabolisation of simple sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to disclose and quantify as many proteins as possible.
Track 1: Proteomics in Drug Discovery
Drug discovery is a lengthy and highly expensive process that uses a variety of tools from diverse fields. To facilitate the process, several biotechnologies, including genomics, proteomics, cellular and organismic methodologies have been developed. The present review aims to provide a basic understanding of proteomics research by discussing the methods used to study large numbers of proteins and by reviewing the application of proteomics methods to identify biomarkers, to identify drug target and to conduct drug’s mode of action and toxicology studies. It is expected that this will lead to important new insights into disease mechanisms and improved drug discovery strategies to produce novel therapeutics.
- Goal of biomarker discovery
- Identification and assignment of candidate target
- Recombinant protein microarray
- Computational drug desig
- Drug toxicity
- Chemical proteomics
Track 2: Protein Expression and Analysis
Protein expression refers to the way in which proteins are synthesized, modified and regulated in living organisms. In protein research, the term can apply to either the object of study or the laboratory techniques required to manufacture proteins. Protein analysis is the bioinformatics study of protein structure, protein interaction and function using database searches, sequence comparisons, structural and functional predictions.
- Protein expression
- Gel-free & based proteomics technique
- Functional proteomics
- Protein biochemistry
- Protein interaction
- Protein identification
- Protein profiling
- Protein characterization
- Protein analysis
- Recombinant proteins
Track 3: Chromatin Proteomics
More than a thousand proteins are thought to contribute to mammalian chromatin and its regulation, but our understanding of the genomic occupancy and function of most of these proteins is limited. We have used a chromatin proteomic profiling approach to produce a catalogue of proteins associated with genomic regions whose chromatin is marked by specific modified histones. A substantial number of the newly identified proteins are associated with human disease. Future chromatin proteomic profiling studies should prove valuable for identifying additional chromatin-associated proteins in a broad spectrum of cell types.
- Chromatin regulators enriched in chip-ms
- Transcription factors and cofactors enriched in chip-ms
- Cell culture
- Chip-ms and chip-seq
Track 4: Protein Microarrays
Protein microarrays, also known as protein chips that provides a versatile platform for characterization of hundreds of thousands of proteins in a highly parallel and high-throughput way. It is an important class of proteomic technologies that are in fast becoming crucial tools in biochemistry and molecular biology. Two major classes of protein microarrays are defined to describe their applications: analytical and functional protein microarrays. Analytical protein microarrays, mostly antibody microarrays, have become one of the most powerful multiplexed detection technologies. Functional protein microarrays are being increasingly applied to many areas of biological discovery, including studies of protein interaction, biochemical activity, and immune responses.
- Analytical protein microarrays
- Functional protein microarrays
- Protein-protein interactions
- Protein-dna interactions
- Proetin-drug interactions
- Identification of kinase substrates on protein chips
- Profiling immune responses
- Detection of antigen-antibody interaction using protein microarrays
Track 5: The Cancer Proteome
Proteomics technologies are used for early detection and diagnosis of cancers for the development of novel therapeutic agents. Identification of biomarker and also the study of protein expression of the cancer are studied through proteomics platforms. These studies have led to the development of discovering new drugs and targeted therapeutics towards the tumour cells. Detection, prognosis, diagnosis and therapy of breast cancer is now possible with the advancements in the field of proteomics along with the use of mass spectrometry. The discovery of the protein patterns has enabled researchers to distinguish the disease and disease free-state associated with breast cancer has been uncovered with the development of proteomics technologies. This discovery leads to personalized therapy for the patients. Proteins expressed or found in the serum, plasma and the tumour cells using the novel methodologies provide a better view of the heterogeneity of the cancers.
- Protein expression of cancer genes
- Genetic alteration
- Somatic mutations
- Missense mutations
- Frameshift mutations
- Germline mutations
- Nonsense mutations
- Splicing mutations
- Tumour biology
Track 6: Proteomics for Bioinformatics
Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data. As an interdisciplinary field of science, bioinformatics combines computer science, statistics, mathematics, and engineering to analyse and interpret biological data.
- Evolutionary bioinformatics
- Structural bioinformatics
- Next generation sequencing
- Web services in bioinformatics
- Programming languages in bioinformatics
- High performance computing in bioinformatics
- Algorithm biology & health informatics
- Applied bioinformatics and public health microbiology
Track 7: Neuroproteomics
Neuroproteomics is the study of the protein complexes and species that make up the nervous system. These proteins interact to make the neurons connect in such a way to create the complication, that nervous system is known for. Neuroproteomics is a complex field that has a long way to go in terms of profiling the entire neuronal proteome. It is a relatively recent field that has many applications in therapy and science. So far, only small subsets of the neuronal proteome have been mapped, and then only when applied to the proteins involved in the synapse. Neuroproteomics is a step in the right direction of identifying bio-markers that can be used to detect diseases.
- Protein separation
- Protein identification
- Drug addiction
- Brain injury
- Nerve growth
- Cellular neuroscience
- Molecular neuroscience
Track 8: Proteomics and Cell Signalling
Most cells in the human body are subject to continuous change. Old or dysfunctional cells are replaced on a regular basis. In addition, each cell is constantly sensing its environment, and can adapt in response to specific cues, if necessary. This is essential to ascertain proper physiological function. All signal transduction processes consist of individual protein-protein interactions, which are assembled into pathways and networks. They are regulated by protein abundance and localization, and modulated by post-translational modifications. Any drug intervention, therefore must alter at least of these features in order for it to be effective.
- Cell signalling in multicellular organisms
- Receptors for cell motility and differentiation
- Signalling pathways
- Intraspecies and interspecies signalling
- Paracrine signalling
- Synaptic signalling
- Autocrine signalling
- Endocrine signalling
- Signalling through cell-cell contact
Track 9: Metabolomics
Metabolomics is a term that describes the measurement and analysis of metabolites, such as sugars and fats, in the cells of organisms at specific times and under specific conditions. Metabolomics allows researchers to measure physiological effects and to monitor for adverse reactions to drugs. Metabolomics is of interest to physicians because it may lead to improvements in the diagnosis and treatments of human diseases.
- Metabolic fingerprinting
- Metabolic Profiling
- Metabolic targeting
- Environmental metabolomics
- Molecular medicine
- Molecular pathology
Track 10: Transcriptome Sequencing
Transcriptome sequencing covers a wide variety of simple mRNA profiling to discovery and analysis of the entire Transcriptome. These, collectively called RNA-Sequence, are extremely popular for next generation sequencing platforms. Since it is a sequencing based techniques, it is well suited for RNA editing and allele specific expression.
- Small rna-seq
- Whole transcriptome sequencing
- Mapping gene and exon boundaries
- Expressed sequences and cdna libraries
- Next-generation sequencing
- Rna purification & transcriptome enrichment
Track 11: Phylogenetic Analysis of Protein
Phylogenetic analysis is the study of evolutionary relationships among molecules, phenotypes, and organisms. In the context of protein sequence data, phylogenetic analysis is one of the milestone of comparative sequence analysis and has many applications in the study of protein evolution and function.
- Data collection
- Inference of homology
- Sequence alignment
- Alignment trimming
- Phylogenetic analysis
- Protein feature sequences
- Phylogenetic tree
Robust interpretation of experimental results computing discreet biological domains remains a significant challenge in the face of complex biochemical regulation processes such as organismal versus tissue versus cellular metabolism, epigenetics, and protein post-translational modification. Integration of analyses carried out across multiple measurement ,is an upcoming approach to help address these challenges. This review focuses on select methods and tools for the integration of metabolomic with genomic and proteomic data using a variety of approaches .
- Pathway or biochemical-ontology-based integration
- Biological-network-based integration
- Empirical correlation analysis
- Data integration
- Data analysis
- Biochemical processes
Pharmaceutical research has successfully incorporated a wealth of molecular modelling methods, within a variety of drug discovery programs, to study complex biological and chemical systems. The integration of computational and experimental strategies has been of great value in the identification and development of novel promising compounds. Broadly used in modern drug design, molecular docking methods explore the ligand conformations adopted within the binding sites of macromolecular targets. This approach also estimates the ligand-receptor binding free energy by evaluating critical phenomena involved in the intermolecular recognition process.
- Molecular modelling
- Drug discovery
- Molecular target
- Molecular interaction
- Virtual screening
- Structure-based drug design
Related Proteomics Conferences | Proteomics Meeting | Proteomics Events:
- 2017 Colorado Protein Stability Conference, June 20-July 17, 2017 Colorado, USA
- 5th International Congress on Analytical Proteomics, July 3-6, 2017 Caparica, Portugal
- Novel Protein Therapeutics July 11-12, 2017 Baltimore, USA
- Proteomics Bioinformatics July 16 -21, 2017 United Kingdom
- The Protein Society's 31st Annual Symposium, July 24 - 27, 2017 Montreal, CA
- Posttranslational Modification Networks Gordon Research Conference August 13-18, 2017 Hong Kong, China
The Bioprocessing Summit, August 21-25, 2017 Boston, US
5th Annual Antibodies against membrane Protein Targets, September 26-27, 2017 Boston, US
- Central and Eastern European Proteomic Conference (CEEPC), September 27-29, 2017 Kosice, Slovakia
- 16th Human Proteome Organization World Congress, September 17- 21, 2017 Dublin, Ireland
- Global Proteomics Conference, October 12-13, 2017 United Arab Emirates
- Global Summit and Expo on Proteomics, November 9-11, 2017 Valencia, Spain
Proteomics Society, India; German Society for Proteomics (DGPF), Germany; Norwegian Proteomics Society, Norway; British Society for Proteome Research (BSPR), UK; Japanese Proteomics Society, Japan; Korean Human Proteome Organization (KHUPO), Biochemical Society, London, UK; European Proteomics Association (EuPA), Europe; Swedish Proteomics Society (SPS), Sweden; Belgian Proteomics Association, Belgium; Danish Proteomics Society (DAPSOC), Denmark; Portuguese Proteomics Association, Portugal; Finnish Proteomics Society, Finland; Austrian Proteomics Association, Austria; Iranian Proteomics Society, Iran; Netherlands Proteomics Centre, Netherland; Swiss Proteomics Society, Switzerland; Turkish Proteomics Association, Turkey; Australasian Proteomics Society, Australia; Canadian Proteomics Organization, Canada; Taiwan Proteomics Society, Taiwan; Human Proteome Organisation, Asia; Czech Proteomic Society, Czech Republic; Spanish Proteomics Society, Spain.
London is the capital and most populous city of England and the United Kingdom. Standing on the River Thames in the south east of the island of Great Britain, London has been a major settlement for two millennia. Since at least the 19th century, "London" has also referred to the metropolis around this core, historically split between Middlesex, Essex, Surrey, Kent, and Hertfordshire, which today largely makes up Greater London, governed by the Mayor of London and the London Assembly. London is the world's leading investment destination, hosting more international retailers and ultra-high-net-worth individuals than any other city. London's universities form the largest concentration of higher education institutes in Europe, and a 2014 report placed it first in the world university rankings. London has a diverse range of people and cultures, and more than 300 languages are spoken in the region. It’s estimated mid-2015 municipal population was 8,673,713 the largest of any city in the European Union, and accounting for 12.5 per cent of the UK population. London's urban area is the second most populous in the EU, after Paris, with 9,787,426 inhabitants at the 2011 census.
Top Attractive Places to Visit in London
Buckingham Palace and the Changing of the Guard: One of Britain's most iconic buildings, Buckingham Palace is also the scene of London's most popular display of pomp and circumstance, the Changing of the Guard. Drawing crowds at 11:30am in every season, this colorful and free display of precision marching and music also takes place at St James's Palace where you can follow the band along The Mall as they march between sites.Buckingham Palace was built in 1837 and has been the London residence of the Royal Family since Queen Victoria's accession.
The British Museum: Displaying one of the world's finest collections of antiquities, the British Museum contains more than 13 million artifacts from the ancient world. With priceless objects from Assyria, Babylonia, China, Europe, and elsewhere, it's hard to know where to begin. But most tourists head first for the museum's most famous exhibits: the controversial Elgin Marbles from the Parthenon, the Rosetta Stone, the colossal bust of Rameses II, the Egyptian mummies, and the spectacular hoard of 4th-century Roman silver known as the Mildenhall Treasure.
The Tower of London and Tower Bridge: The magnificent Tower of London has fulfilled many different roles down the centuries. One of Britain's most iconic structures, this spectacular World Heritage Site offers hours of fascination for visitors curious about the country's rich history - after all, so much of it happened here. Inside the massive White Tower, built in 1078 by William the Conqueror, is the 17th-century Line of Kings with its remarkable displays of royal armaments and armor.
Big Ben and Parliament: Nothing says "London" more emphatically than the 97-meter tower housing the giant clock and its resounding bell known as Big Ben. It's as iconic a landmark as Tower Bridge.
The London Eye: Built to mark London's millennium celebrations in 2000, the London Eye is Europe's largest observation wheel. Its individual glass capsules offer the most spectacular views of the city as you embark on a circular tour rising 443 ft above the Thames.
St Paul's Cathedral: The largest and most famous of London's many churches - and undoubtedly one of the most spectacular cathedral's in the world - St Paul's Cathedral sits atop the site of a Roman temple. The previous church structure was destroyed in the Great Fire of 1666, and Sir Christopher Wren designed the re-build. Today, the twin Baroque towers and magnificent 365 ft dome of St Paul's are a masterpiece of English architecture. If you're up to it, be sure to walk the stairs with their spectacular views of the dome's interior, including the Whispering Gallery.
Global Top Proteomics Universities
USA Proteomics Universities
Harvard University | Massachusetts Institute of Technology | Stanford University | University of California Berkeley | California Institute of Technology | Johns Hopkins University | University of California San Francisco | Yale University | Princeton University | Scripps Research Institute | Cornell University | Duke University | Washington University in St. Louis| Columbia University | Rockefeller University | University of California San Diego | University of Chicago | University of Wisconsin Madison | University of Michigan | University of Pennsylvania | University of Washington | North western University | Vanderbilt University | Emory University | University of Texas | Brown University | Indiana University | University of Arizona | Ohio State University | University of Alabama | University of Pittsburgh | Michigan State University | University of Virginia | Arizona State University| Brandeis University | Georgia Institute of Technology | University of Florida | Purdue University | University of Maryland | New York University | University of Utah | University of Kansas | University of Rochester | Colorado State University | Boston University | Florida State University | Wesleyan University | Miami University | Albany Medical College |
European Proteomics Universities
University of Oxford | University of Cambridge | University of Copenhagen | University College London | Imperial College London | Swiss Federal Institute of Technology Zurich | University of Zurich | Karolinska Institute | University of Munich | University of Edinburgh | Pierre and Marie Curie University | Heidelberg University | University of Manchester | Catholic University of Leuven | University of Helsinki | Freie Universität Berlin| Utrecht University | Uppsala University | Wageningen University and Research Center | Humboldt-Universität zu Berlin | University of Groningen | University of Barcelona | Technical University of Munich | Leiden University | University of Basel | University of Strasbourg | Ghent University | King's College London | University of Geneva | University of Dundee | Lund University | Johann Wolfgang Goethe University Frankfurt am Main| University of Göttingen | University of Freiburg| Stockholm University | University of Gothenburg | University of Sheffield | Eberhard Karls University, Tübingen | University of Padua | University of Würzburg | Université Paris-Sud | University of Vienna | University of Bristol | Free University of Brussels | University of Milan| University of Amsterdam | University of Nottingham | University of Hamburg | University of Oslo | University of Leeds |University of Birmingham | University of Southampton | University of Bern | University of Cologne | Medical University of Vienna |University of Münster | University of Lisbon | University College Dublin | University of Aberdeen | University of Liverpool | Trinity College Dublin | Delft University of Technology| Bielefeld University | University of Leipzig | Cardiff University | University of York | University of Regensburg | University of Warsaw |
Asian Proteomics Universities
University of Tokyo | National University of Singapore | Kyoto University | Peking University| Tsinghua University | Weizmann Institute of Science | Osaka University | Seoul National University | Shanghai Jiao Tong University | Fudan University | Zhejiang University | Tel Aviv University | Hebrew University of Jerusalem | University of Hong Kong | Tohoku University | Nanyang Technological University | Korea Advanced Institute of Science and Technology| Hokkaido University | National Taiwan University | Keio University | Shandong University | Nagoya University | Sungkyunkwan University | Yonsei University | Kyushu University | Sun Yat-sen University | Huazhong University of Science and Technology | Wuhan University | University of Science and Technology of China | Tokyo Institute of Technology | Tokyo Institute of Technology | King Abdulaziz University | National Cheng Kung University | Kobe University | Korea University | Pohang University of Science and Technology | Indian Institute of Science | Nankai University | Tongji University | King Saud University | Nanjing University | Harbin Institute of Technology | University of Tsukuba| Kyung Hee University | Sichuan University|Xiamen University | Chonnam National University | Jilin University | Central South University | University of Tehran | Aligarh Muslim University | Chinese University Hong Kong | University of Delhi | South China University of Technology | Waseda University | Okayama University | Southeast University |Soochow University | Mahidol University | Hiroshima University | Tianjin Medical University | Kanazawa University | Tehran University of Medical Sciences | Kumamoto University | Kyungpook National University | National Yang-Ming University | China Medical University Taiwan |
Australia & NewZealand Proteomics Universities
University of Queensland Australia | University of Melbourne | University of Sydney | Monash University | University of New South Wales | University of Western Australia | University of Auckland | University of Otago | University of Adelaide | Australian National University | University of Queensland Australia |
Major Proteomics Societies
Human Proteome Organization | European Proteomics Association (Eupa)| Spanish Proteomics Society– (Seprot)| Netherlands Proteomic Platform (Npp)| Japan Human Proteome Organisation (Jhupo)| Italian Proteomic Association (Itpa)| Portugese Proteomic Association (Rede Procura)| Iranian Proteomic Society| Taiwan Proteomic Society (Tps)| Austrian Proteomics Society| European Proteomics Association| British Mass Spectrometry Society| Belgian Mass Spectrometry Society| Danish Mass Spectrometry Society| Australian and New Zealand Mass Spectrometry Society| Indiana Proteomics Consortium| Proteome Society| European federation of biotechnology| Australasian Proteomics Society |
Related Conferences to Proteomics
3rd International Enzymology Conferences, March 05-06, 2018 London, UK | 12th International Metabolomics Conferences, May 14-15, 2018, Baltimore, USA | 13th Systems Biology Conferences, June 11-12, 2018 London, UK | 4th Glycobiology Congress, September 17-19, 2018, Rome, Italy | Biochemical Basis of Respiratory Disease, January 08-10, 2018, England | Shaping your career in Molecular Biosciences: Taking a wider view, January 15, 2018, London, UK | The Dynamic Cell III March 19-21, 2018, Manchester; New Horizons in ESCRT Biology, April 17-20, 2018, London | 30th Annual RNA Polymerase focused Meeting April 19-20, 2018, London, UK | Experimental techniques for studying proteins and lipids in Biological Membranes, May 15-16, 2018, UK | Structure and Mechanism of Membrane Proteins May17-18, 2018, UK | Small G Proteins in Cellular Signalling and Disease, July 09-12, 2018, Cambridge, UK |
Major Proteomics Related Research Units
Structural Biology Group, RIKEN | OKINAWA Institute of Science and Technology | Markey Center for Structural Biology | New York Structural Biology Center | Department of Anatomy and Structural Biology, Einstein College | Department of Structural and Cellular Biology - Tulane University | Structural Biology, Penn State University | Chemical and Structural Biology – The Rockfeller University | Center for Structural Biology - University of Illinois at Chicago | Structural Biology Facility - Robert H. Lurie Comprehensive Cancer Center of Northwestern University | Department of Cellular and Structural Biology – UT Health Science Center | UCSF Macromolecular Structure Group | Structural Biology NMR Facility - University of Minnesota
Proteomics Job Opportunities
Membrane Protein Structural Biologist ,Institute For Biomedical Informatics | Scientist, X-Ray Crystallography , Johnson & Johnson Family of Companies | Research Associate – Experimental Structural Molecular Biology, SLAC National Accelerator Laboratory| Postdoctoral Fellow, University of Delaware | Research Associate Scientist, Protein Science, Johnson & Johnson Family of Companies | Structural Biology Research Technician, Clinical Research Management | Staff Scientist - Structural Biology ,St. Jude Children's Research Hospital | Research Technician - Molecular Biology and Microbiology, TUFTS University | Postdoctoral Fellow- Structural and Molecular Sciences , Pfizer | Structural Biology Laboratory Assistant Professor , UT Southwestern Medical Center | Manager, AAV Structural Biologist, Rare Disease , Pfizer Inc.| Co-Op, Structural Biology & Biophysics , Vertex Pharmaceuticals | Basic Life Research Scientist , Stanford University | Process Development Scientist, Sequencing, Roche | Postdoctoral Associate , Rutgers University | Physical Organic Chemist , Los Alamos National Laboratory | Laboratory Specialist, Biology , Pima Community College | Sr Consultant - Structural Biology , Thermo Fisher Scientific | Research Technologist II - Protein Biophysics / Molecular Biology, Medical College of Wisconsin | Research Associate , Institute For Biomedical Informatics - United States | Postdoctoral Associate, Howard Hughes Medical Institute | Associate Scientist II / Scientist I - Biophysics , AbbVie , South San Francisco, CA | Postdoctoral Research Associate, National Jewish Health | Postdoctoral fellow in Biochemistry and Structural Biology, SciLifeLab | Hanna H. Gray Fellow, Howard Hughes Medical Institute | Faculty Position in Biophysics, University of Texas Southwestern Medical Center | Assistant Professor Tenure Track, Washington State University, Institute of Biological Chemistry | Assistant, Associate or Professor in Cryo-EM, University of Utah Biology Department | Assistant/Associate Professor – Structural Biology/Protein NMR, Medical University of South Carolina |